Trials
Search / Trial NCT05656937

Oblique Versus Transverse Orientation Approach for Internal Jugular Venous Cannulation in Pediatrics

Launched by INDONESIA UNIVERSITY · Dec 16, 2022

Trial Information

Current as of January 14, 2025

Completed

Keywords

Oblique Orientation Transverse Orientation Internal Jugular Venous Cannulation Ultrasound Guided Short Axis Oblique Axis

ClinConnect Summary

Sixty patients randomised into two groups, 30 patients in experimental group (oblique orientation) and 30 patients in control group (transverse orientation). All cannulation took place in the operation room. Patients underwent general anesthesia and placed in supine position. Standard monitoring (electrocardiogram, non-invasive arterial pressure, pulseoxymetry) was carried out during the procedure for all patients. Before preparation of the skin, a pre-procedure ultrasound examination was performed to verify internal jugular vein patency, and its diameter was measured. Once the side had bee...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients age 3 months to 12 years old, weight 5-20 kg, male or female
  • who undergo heart surgery and indicated to have central venous cannulation
  • American Society of Anesthesiologist Physical Class 1-3
  • Family or representation of the patients agreed to participate in this study and sign informed consent
  • Exclusion Criteria:
  • history of surgery in the area of cannulation
  • already placed central venous cannulation \<72 hours in the same venous
  • sign of infection, hematoma, emphysema, in the area of cannulation
  • history of cervical trauma
  • severe hemostatic disorder (International Normalized Ratio\>2, thrombocyte \<50.000, Prothrombin time\>1.5 times, Activated Partial Thromboplastin Time \> 1.5 times

Trial Officials

aldy heriwardito, Doctor

Principal Investigator

Indonesia University

About Indonesia University

Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.

Locations

Jakarta, , Indonesia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials